Stockholm, Sweden – Barnik Invest Group today announced the bolagization of its joint venture project with DynalisPharma, resulting in the formation of BoniPharmex AB. This strategic move solidifies the partnership and positions BoniPharmex for significant growth in the market for probiotics and dietary supplements
BoniPharmex was initially founded in 2021 as a joint venture between StartUpPharma Int. AB, a Swedish company with extensive expertise in clinical, regulatory affairs, marketing, and distribution of medical devices and food supplements, and DynalisPharma, a Swiss company with three decades of experience in developing and manufacturing medical devices and food supplements.
“We are excited to further strengthen our partnership with DynalisPharma through the creation of BoniPharmex AB. This new company will leverage the combined expertise of both organizations to continue bringing innovative and impactful probiotics and food supplements to the market,” said Hamid Bakhshi, CEO of Barnik Invest Group.
BoniPharmex AB will now operate as an independent entity, allowing for greater flexibility and agility in pursuing its business objectives.
For more information, please contact;
Hamid Bakhshi, CEO
Telephone: +46738531165
E-mail: hamid.bakhshi@barnikinvest.com
About Barnik Invest Group
Barnik Invest Group is a leading 360 solution partner for small Life Science companies in the Nordics. The company provides a comprehensive suite of services to support its portfolio companies, including capital, clinical development, expertise, and commercialization. Through its fully-owned subsidiaries, Medicorent and StartUpPharma, Barnik Invest offers CRO services, outsourcing, recruitment, distribution, product development and commercialization solutions. Barnik’s mission is to nurture promising life science companies from early clinical development phase to commercialization, enabling them to achieve positive cash flows or successful exits and ultimately enhancing patient well-being and improving human health worldwide. For more information visit www.barnikinvest.com.
